The spectrum of heart failure: current concepts in defining systolic and diastolic cardiac dysfunction.

Back

ESC Professional Premium Access

The spectrum of heart failure: current concepts in defining systolic and diastolic cardiac dysfunction.

Session: Making best use of the new drugs: ARNI and SGLT2 inhibitors across the spectrum of heart failure

Topic: Cardiovascular Pharmacotherapy

Speaker: Professor C. Ceconi (Desenzano Del Garda, IT)

Event: ESC Congress 2022

Congress Presentation

About the speaker

Professor Claudio Ceconi

Unit of Cardiology, Desenzano Del Garda (Italy)

8 presentations

0 follower

3 more presentations in this session

ARNI: evidence across the spectrum of heart failure.

Speaker: Professor M. Packer (Dallas, US)

Access

Slides

Video

SGLT2 inhibitors: evidence across the spectrum of heart failure.

Speaker: Professor S. Anker (Berlin, DE)

Access

Slides

Video

Putting it all together: ARNI, SGLT2 inhibitors and other drugs across the spectrum of heart failure.

Speaker: Doctor E. O'Meara (Montreal, CA)

Access

Slides

Video

Access the full session

Making best use of the new drugs: ARNI and SGLT2 inhibitors across the spectrum of heart failure

Speakers: Professor C. Ceconi, Professor M. Packer, Professor S. Anker, Doctor E. O'Meara

Access

Video

About the event

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress

The spectrum of heart failure: current concepts in defining systolic and diastolic cardiac dysfunction.

About the speaker

Professor Claudio Ceconi

3 more presentations in this session

ARNI: evidence across the spectrum of heart failure.

SGLT2 inhibitors: evidence across the spectrum of heart failure.

Putting it all together: ARNI, SGLT2 inhibitors and other drugs across the spectrum of heart failure.

Access the full session

Making best use of the new drugs: ARNI and SGLT2 inhibitors across the spectrum of heart failure

About the event

ESC Congress 2022

ESC 365 is supported by